AdaptHealth Corp. (AHCO) vs Lexicon Pharmaceuticals, Inc. (LXRX)
A side-by-side comparison of AdaptHealth Corp. and Lexicon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LXRX
Lexicon Pharmaceuticals, Inc.
$1.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AHCO vs LXRX
growth of $100 · dividends reinvested · last 8yAHCO -40.8% (-6.3%/yr)LXRX -82.3% (-19.5%/yr)AHCO compounded faster over this window
AHCO LXRX
AHCO vs LXRX: by the numbers
- •AHCO is the larger company ($785M vs $777M market cap).
- •Both run net losses; AHCO's is the smaller (-7.58% vs -147.38% net margin).
- •LXRX grew revenue faster over the past five years (42.36% vs 11.68% CAGR).
Metrics side by side
Valuation
| Metric | AHCO | LXRX |
|---|---|---|
| P/S ratio | 0.26 | 18.75 |
| P/B ratio | 0.57 | 4.45 |
| EV / EBITDA | 6.63 | N/A |
| FCF yield | 12.44% | N/A |
Profitability
| Metric | AHCO | LXRX |
|---|---|---|
| Gross margin | 10.37% | 98.85% |
| Operating margin | -0.31% | -98.21% |
| Net margin | -7.58% | -147.38% |
| ROE | -16.56% | -35.02% |
| ROIC | -0.26% | -23.16% |
Growth (annualized)
| Metric | AHCO | LXRX |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | 42.36% |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -18.54% |
Frequently asked
- Which has grown faster, AHCO or LXRX?
- Over the past five years, LXRX grew revenue faster — AHCO at a 11.68% CAGR versus LXRX at 42.36%.
- How have AHCO and LXRX total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and LXRX delivered -18.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROELexicon Pharmaceuticals ROEAdaptHealth operating marginLexicon Pharmaceuticals operating marginAdaptHealth revenue growthLexicon Pharmaceuticals revenue growthAdaptHealth free cash flowLexicon Pharmaceuticals free cash flow
AdaptHealth & Lexicon Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.